199 related articles for article (PubMed ID: 19289492)
1. Pseudoprogression in boron neutron capture therapy for malignant gliomas and meningiomas.
Miyatake S; Kawabata S; Nonoguchi N; Yokoyama K; Kuroiwa T; Matsui H; Ono K
Neuro Oncol; 2009 Aug; 11(4):430-6. PubMed ID: 19289492
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab treatment of symptomatic pseudoprogression after boron neutron capture therapy for recurrent malignant gliomas. Report of 2 cases.
Miyatake S; Furuse M; Kawabata S; Maruyama T; Kumabe T; Kuroiwa T; Ono K
Neuro Oncol; 2013 Jun; 15(6):650-5. PubMed ID: 23460324
[TBL] [Abstract][Full Text] [Related]
3. Boron neutron capture therapy for malignant tumors related to meningiomas.
Miyatake S; Tamura Y; Kawabata S; Iida K; Kuroiwa T; Ono K
Neurosurgery; 2007 Jul; 61(1):82-90; discussion 90-1. PubMed ID: 17621022
[TBL] [Abstract][Full Text] [Related]
4. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
[TBL] [Abstract][Full Text] [Related]
5. Boron neutron capture therapy for recurrent high-grade meningiomas.
Kawabata S; Hiramatsu R; Kuroiwa T; Ono K; Miyatake S
J Neurosurg; 2013 Oct; 119(4):837-44. PubMed ID: 23808536
[TBL] [Abstract][Full Text] [Related]
6. Boron Neutron Capture Therapy for Malignant Brain Tumors.
Miyatake S; Kawabata S; Hiramatsu R; Kuroiwa T; Suzuki M; Kondo N; Ono K
Neurol Med Chir (Tokyo); 2016 Jul; 56(7):361-71. PubMed ID: 27250576
[TBL] [Abstract][Full Text] [Related]
7. PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma.
Nariai T; Ishiwata K; Kimura Y; Inaji M; Momose T; Yamamoto T; Matsumura A; Ishii K; Ohno K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S348-50. PubMed ID: 19375930
[TBL] [Abstract][Full Text] [Related]
8. Boron neutron capture therapy for malignant brain tumors.
Miyatake SI; Wanibuchi M; Hu N; Ono K
J Neurooncol; 2020 Aug; 149(1):1-11. PubMed ID: 32676954
[TBL] [Abstract][Full Text] [Related]
9. Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases.
Miyatake S; Kawabata S; Hiramatsu R; Furuse M; Kuroiwa T; Suzuki M
Radiat Oncol; 2014 Jan; 9():6. PubMed ID: 24387301
[TBL] [Abstract][Full Text] [Related]
10. BNCT for recurrent intracranial meningeal tumours - case reports.
Stenstam BH; Pellettieri L; Sorteberg W; Rezaei A; Sköld K
Acta Neurol Scand; 2007 Apr; 115(4):243-7. PubMed ID: 17376121
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and therapeutic indicator of fluoroboronophenylalanine positron emission tomography in patients with gliomas.
Takahashi Y; Imahori Y; Mineura K
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5888-95. PubMed ID: 14676111
[TBL] [Abstract][Full Text] [Related]
12. Advances in Boron Neutron Capture Therapy (BNCT) for Recurrent Intracranial Meningioma.
Lan TL; Lin CF; Lee YY; Lin KH; Chang FC; Lin SC; Lee JC; Chou FI; Peir JJ; Liu HM; Mu PF; Chen YW
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902408
[TBL] [Abstract][Full Text] [Related]
13. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
[TBL] [Abstract][Full Text] [Related]
14. Boron Neutron Capture Therapy of Malignant Gliomas.
Miyatake SI; Kawabata S; Hiramatsu R; Kuroiwa T; Suzuki M; Ono K
Prog Neurol Surg; 2018; 32():48-56. PubMed ID: 29990973
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
Wang HE; Liao AH; Deng WP; Chang PF; Chen JC; Chen FD; Liu RS; Lee JS; Hwang JJ
J Nucl Med; 2004 Feb; 45(2):302-8. PubMed ID: 14960653
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
[TBL] [Abstract][Full Text] [Related]
17. Early effects of boron neutron capture therapy on rat glioma models.
Nakagawa N; Akai F; Fukawa N; Fujita Y; Suzuki M; Ono K; Taneda M
Brain Tumor Pathol; 2007; 24(1):7-13. PubMed ID: 18095138
[TBL] [Abstract][Full Text] [Related]
18. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
[TBL] [Abstract][Full Text] [Related]
19. Radiation-induced meningiomas after BNCT in patients with malignant glioma.
Kageji T; Sogabe S; Mizobichi Y; Nakajima K; Shinji N; Nakagawa Y
Appl Radiat Isot; 2015 Dec; 106():256-9. PubMed ID: 26122975
[TBL] [Abstract][Full Text] [Related]
20. Survival benefit of boron neutron capture therapy for recurrent malignant gliomas.
Miyatake S; Kawabata S; Yokoyama K; Kuroiwa T; Michiue H; Sakurai Y; Kumada H; Suzuki M; Maruhashi A; Kirihata M; Onoc K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S22-4. PubMed ID: 19394240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
